| STI Continues to Grow with an Expanded Product Portfolio |
| Posted at : 17 Oct 2008 |
STI is excited to announce that since 2003 we have developed over 120 programs and have worked with 8 of the top 10 pharmaceutical companies in Canada. We continue to grow dramatically every year by launching programs for some of the most innovative pharmaceutical manufacturers.
STI has expanded the SmartTechnology™ product portfolio to include SmartSample, SmartRx™, SmartPayment™ and soon to be launched, SmartCoverage™. SmartSample (including SmartRx™) accounts for 60% of all SmartTechnology™ programs, while SmartPayment™ accounts for the remaining 40% of programs.
SmartTechnology™ offers a diverse line of innovative products and programs that have helped revolutionize the alternative sample marketing, clinical trial and device markets. Patient safety is improved by involving both the Physician and Pharmacist in patient counseling and the delivery of quality controlled sample medication and medical devices from retail pharmacies. |
|
